Epiminder Ltd (ASX: EPI) Share Price and News

Mr Sells is the Chief Financial Officer of Healthscope Operations Pty Limited, a national private hospital operation and healthcare provider with a network of 38 hospitals. Jeff has a understanding of the healthcare industry and commerce more generally, having worked in chief financial officer roles and led business units for over 25 years. Prior to joining Healthscope in 2024, Jeff worked at Sigma Healthcare Limited for 12 years finishing as the Chief Commercial Officer responsible for a wholesale and retail business and prior to that he was Sigmas Chief Financial Officer. Prior to Sigma, Jeff held chief financial officer roles in the resources sector at Oxiana Limited and Citadel Resource Group Limited. Mr Sells is Chair of the Risk Committee.

--

Mr Klupacs is the Chief Executive Officer of the Bionics Institute. Robert is an Australian qualified patent attorney who has had a career to date within both private and publicly traded companies as well as the academic arena. Robert is also the founder of 28 start up companies and with over 30 of years corporate experience, in translating and commercialising early stage intellectual property into commercial product or investable corporate vehicles.

Ms ORourke has more than 35 years of experience in the health and research industry, including both the public and private sectors. She has held numerous board, chief executive and executive leadership positions during this time. She is currently a non executive director of Australian Unity, a national social enterprise in health, wealth and care . She has also held director roles with the GARVAN Institute of Medical Research, St Vincents Institute of Medical Research, Aikenhead Centre for Medical Discovery (ACMD), the Victorian Endowment for Science, Knowledge and Innovation (VESKI) and Monash Health. Patricia was previously the Chief Executive Officer of the Private Hospitals Division at St Vincents Health Australia, after spending nearly 36 years at St Vincents in various clinical director and operations and chief executive officer roles.She is a member of Risk Committee.

Mr Binns has over 30 years of experience leading organisations across the scientific and life science industries. Philip was recently President of US based Agilent Technologies, Incs Life Sciences and Applied Markets Group, retiring in April 2025. In 2008, Philip was appointed by the Federal Government to chair the Future Manufacturing Innovation Council and in 2012 served on the Prime Ministers Manufacturing Task Force. Philip is a board member of Lightcast Discovery Ltd, the Bionics Institute and is a National Advisory Councilor for the Australian Industry Group .Philip is also an active investor and mentor in early stage technology based companies.

Dr Hoare has experience in medical devices both in large established med tech companies (St. Jude Medical, Inc. and Cyberonics, Inc. (now part of Liva Nova PLC)) and start ups (EndoStim, Inc. and Brainmatterz LLC). Rohan is also an alumni of McKinsey & Company, a global management consulting firm. Rohan is a director of Brainmatterz and Xnerve. In addition, Rohan is on the board of the Epilepsy Foundation of Texas.

-

-

-

-